Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement, Expensed and Capitalized, Amount

The following table summarizes our share-based compensation expense, which consists of the company's RSU expense, by line item in our condensed consolidated statements of income (in millions):


	Three Months Ended March 31,
	2023		2022
Cost of revenue	$	160	$	160
Research and development	2,449		1,941
Marketing and sales	219		216
General and administrative	223		181
Total share-based compensation expense	$	3,051	$	2,498

Restricted Stock Units Award Activity

The following table summarizes the activities for our unvested RSUs for the three months ended March 31, 2023:


	Number of Shares	Weighted-Average Grant Date Fair Value Per Share
	(in thousands)
Unvested at December 31, 2022	127,110	$	216.93
Granted	105,156	$	196.27
Vested	(13,612)	$	211.80
Forfeited	(3,262)	$	229.43
Unvested at March 31, 2023	215,392	$	206.98